Report Detail

Other Global Enzyme Replacement Therapy Market Growth (Status and Outlook) 2019-2024

  • RnM3002384
  • |
  • 22 February, 2019
  • |
  • Global
  • |
  • 136 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.
The classification of enzyme replacement therapy includes injectable agents and oral agents, and the revenue proportion of injectable agents in 2017 is about 62.38%, and the proportion is in increasing trend from 2013 to 2017.
North America is the largest consumption place, with a consumption market share nearly 70.77% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 21.25%.
Market competition is intense. Sanofi, Shire, BioMarin, AbbVie , etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Enzyme Replacement Therapy market will register a 13.4% CAGR in terms of revenue, the global market size will reach US$ 15800 million by 2024, from US$ 7400 million in 2019. In particular, this report presents the global revenue market share of key companies in Enzyme Replacement Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Enzyme Replacement Therapy market by product type, application, key companies and key regions.

This study considers the Enzyme Replacement Therapy value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Injectable Agents
Oral Agents
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Gaucher Disease
Fabry Disease
MPS Disease
Gastrointestinal Disease
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Shire
BioMarin
AbbVie 
Alexion
Allergan
Horizon Pharma
Johnson & Johnson
Actelion
Recordati Rare Diseases
Pfizer
Digestive Care
Leadiant Biosciences

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Enzyme Replacement Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Enzyme Replacement Therapy market by identifying its various subsegments.
Focuses on the key global Enzyme Replacement Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Enzyme Replacement Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Enzyme Replacement Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Enzyme Replacement Therapy Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Enzyme Replacement Therapy Market Size 2014-2024
        • 2.1.2 Enzyme Replacement Therapy Market Size CAGR by Region
      • 2.2 Enzyme Replacement Therapy Segment by Type
        • 2.2.1 Injectable Agents
        • 2.2.2 Oral Agents
      • 2.3 Enzyme Replacement Therapy Market Size by Type
        • 2.3.1 Global Enzyme Replacement Therapy Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Enzyme Replacement Therapy Market Size Growth Rate by Type (2014-2019)
      • 2.4 Enzyme Replacement Therapy Segment by Application
        • 2.4.1 Gaucher Disease
        • 2.4.2 Fabry Disease
        • 2.4.3 MPS Disease
        • 2.4.4 Gastrointestinal Disease
        • 2.4.5 Others
      • 2.5 Enzyme Replacement Therapy Market Size by Application
        • 2.5.1 Global Enzyme Replacement Therapy Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Enzyme Replacement Therapy Market Size Growth Rate by Application (2014-2019)

      3 Global Enzyme Replacement Therapy by Players

      • 3.1 Global Enzyme Replacement Therapy Market Size Market Share by Players
        • 3.1.1 Global Enzyme Replacement Therapy Market Size by Players (2017-2019)
        • 3.1.2 Global Enzyme Replacement Therapy Market Size Market Share by Players (2017-2019)
      • 3.2 Global Enzyme Replacement Therapy Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Enzyme Replacement Therapy by Regions

      • 4.1 Enzyme Replacement Therapy Market Size by Regions
      • 4.2 Americas Enzyme Replacement Therapy Market Size Growth
      • 4.3 APAC Enzyme Replacement Therapy Market Size Growth
      • 4.4 Europe Enzyme Replacement Therapy Market Size Growth
      • 4.5 Middle East & Africa Enzyme Replacement Therapy Market Size Growth

      5 Americas

      • 5.1 Americas Enzyme Replacement Therapy Market Size by Countries
      • 5.2 Americas Enzyme Replacement Therapy Market Size by Type
      • 5.3 Americas Enzyme Replacement Therapy Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Enzyme Replacement Therapy Market Size by Countries
      • 6.2 APAC Enzyme Replacement Therapy Market Size by Type
      • 6.3 APAC Enzyme Replacement Therapy Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Enzyme Replacement Therapy by Countries
      • 7.2 Europe Enzyme Replacement Therapy Market Size by Type
      • 7.3 Europe Enzyme Replacement Therapy Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Enzyme Replacement Therapy by Countries
      • 8.2 Middle East & Africa Enzyme Replacement Therapy Market Size by Type
      • 8.3 Middle East & Africa Enzyme Replacement Therapy Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Enzyme Replacement Therapy Market Forecast

      • 10.1 Global Enzyme Replacement Therapy Market Size Forecast (2019-2024)
      • 10.2 Global Enzyme Replacement Therapy Forecast by Regions
        • 10.2.1 Global Enzyme Replacement Therapy Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Enzyme Replacement Therapy Forecast by Type
      • 10.8 Global Enzyme Replacement Therapy Forecast by Application

      11 Key Players Analysis

      • 11.1 Sanofi
        • 11.1.1 Company Details
        • 11.1.2 Enzyme Replacement Therapy Product Offered
        • 11.1.3 Sanofi Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Sanofi News
      • 11.2 Shire
        • 11.2.1 Company Details
        • 11.2.2 Enzyme Replacement Therapy Product Offered
        • 11.2.3 Shire Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Shire News
      • 11.3 BioMarin
        • 11.3.1 Company Details
        • 11.3.2 Enzyme Replacement Therapy Product Offered
        • 11.3.3 BioMarin Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 BioMarin News
      • 11.4 AbbVie
        • 11.4.1 Company Details
        • 11.4.2 Enzyme Replacement Therapy Product Offered
        • 11.4.3 AbbVie Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 AbbVie News
      • 11.5 Alexion
        • 11.5.1 Company Details
        • 11.5.2 Enzyme Replacement Therapy Product Offered
        • 11.5.3 Alexion Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Alexion News
      • 11.6 Allergan
        • 11.6.1 Company Details
        • 11.6.2 Enzyme Replacement Therapy Product Offered
        • 11.6.3 Allergan Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Allergan News
      • 11.7 Horizon Pharma
        • 11.7.1 Company Details
        • 11.7.2 Enzyme Replacement Therapy Product Offered
        • 11.7.3 Horizon Pharma Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Horizon Pharma News
      • 11.8 Johnson & Johnson
        • 11.8.1 Company Details
        • 11.8.2 Enzyme Replacement Therapy Product Offered
        • 11.8.3 Johnson & Johnson Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Johnson & Johnson News
      • 11.9 Actelion
        • 11.9.1 Company Details
        • 11.9.2 Enzyme Replacement Therapy Product Offered
        • 11.9.3 Actelion Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Actelion News
      • 11.10 Recordati Rare Diseases
        • 11.10.1 Company Details
        • 11.10.2 Enzyme Replacement Therapy Product Offered
        • 11.10.3 Recordati Rare Diseases Enzyme Replacement Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Recordati Rare Diseases News
      • 11.11 Pfizer
      • 11.12 Digestive Care
      • 11.13 Leadiant Biosciences

      12 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Enzyme Replacement Therapy . Industry analysis & Market Report on Enzyme Replacement Therapy is a syndicated market report, published as Global Enzyme Replacement Therapy Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Enzyme Replacement Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,840.16
      4,260.24
      5,680.32
      3,411.12
      5,116.68
      6,822.24
      564,701.40
      847,052.10
      1,129,402.80
      308,611.20
      462,916.80
      617,222.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report